These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9153408)

  • 1. Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein.
    Bosch I; Dunussi-Joannopoulos K; Wu RL; Furlong ST; Croop J
    Biochemistry; 1997 May; 36(19):5685-94. PubMed ID: 9153408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport of phosphatidylserine via MDR1 (multidrug resistance 1)P-glycoprotein in a human gastric carcinoma cell line.
    Pohl A; Lage H; Müller P; Pomorski T; Herrmann A
    Biochem J; 2002 Jul; 365(Pt 1):259-68. PubMed ID: 12071854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 12-O-tetradecanoylphorbol-13-acetate inhibits aminophospholipid translocase activity and modifies the lateral motions of fluorescent phospholipid analogs in the plasma membrane of bovine aortic endothelial cells.
    Julien M; Millot C; Tocanne JF; Tournier JF
    Exp Cell Res; 1997 Jul; 234(1):125-31. PubMed ID: 9223377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of phosphatidylcholine in MDR3-negative epithelial cell lines via drug-induced MDR1 P-glycoprotein.
    Abulrob AG; Gumbleton M
    Biochem Biophys Res Commun; 1999 Aug; 262(1):121-6. PubMed ID: 10448079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: outward-directed transport by the multidrug resistance protein 1 (MRP1).
    Dekkers DW; Comfurius P; Schroit AJ; Bevers EM; Zwaal RF
    Biochemistry; 1998 Oct; 37(42):14833-7. PubMed ID: 9778357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the transbilayer and lateral motions of fluorescent analogs of phosphatidylcholine and phosphatidylethanolamine in the apical plasma membrane of bovine aortic endothelial cells.
    Julien M; Tournier JF; Tocanne JF
    Exp Cell Res; 1993 Oct; 208(2):387-97. PubMed ID: 8375469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line.
    Hu XF; Slater A; Rischin D; Kantharidis P; Parkin JD; Zalcberg J
    Br J Cancer; 1999 Feb; 79(5-6):831-7. PubMed ID: 10070877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dithionite quenching rate measurement of the inside-outside membrane bilayer distribution of 7-nitrobenz-2-oxa-1,3-diazol-4-yl-labeled phospholipids.
    Angeletti C; Nichols JW
    Biochemistry; 1998 Oct; 37(43):15114-9. PubMed ID: 9790674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A non-exchangeable fluorescent phospholipid analog as a membrane traffic marker of the endocytic pathway.
    Willem J; ter Beest M; Scherphof G; Hoekstra D
    Eur J Cell Biol; 1990 Oct; 53(1):173-84. PubMed ID: 2076704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.
    Majumder S; Dutta P; Mukherjee P; Datta ER; Efferth T; Bhattacharya S; Choudhuri SK
    Cancer Lett; 2006 Nov; 244(1):16-23. PubMed ID: 16410038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.
    Lee CG; Gottesman MM; Cardarelli CO; Ramachandra M; Jeang KT; Ambudkar SV; Pastan I; Dey S
    Biochemistry; 1998 Mar; 37(11):3594-601. PubMed ID: 9530286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
    Romsicki Y; Sharom FJ
    Biochemistry; 1999 May; 38(21):6887-96. PubMed ID: 10346910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines.
    Cass CE; Janowska-Wieczorek A; Lynch MA; Sheinin H; Hindenburg AA; Beck WT
    Cancer Res; 1989 Nov; 49(21):5798-804. PubMed ID: 2790792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A flow cell assay for evaluation of whole cell drug efflux kinetics: analysis of paclitaxel efflux in CCRF-CEM leukemia cells overexpressing P-glycoprotein.
    Lin JT; Sharma R; Grady JJ; Awasthi S
    Drug Metab Dispos; 2001 Feb; 29(2):103-10. PubMed ID: 11159798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of membrane phospholipid composition and structural organization on spontaneous lipid transfer between membranes.
    Pankov R; Markovska T; Antonov P; Ivanova L; Momchilova A
    Gen Physiol Biophys; 2006 Sep; 25(3):313-24. PubMed ID: 17197729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein does not reduce substrate concentration from the extracellular leaflet of the plasma membrane in living cells.
    Chen Y; Pant AC; Simon SM
    Cancer Res; 2001 Nov; 61(21):7763-9. PubMed ID: 11691790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural changes related to multidrug resistance in CEM cells: role of cytoplasmic vesicles in drug exclusion.
    Bobichon H; Colin M; Depierreux C; Liautaud-Roger F; Jardillier JC
    J Exp Ther Oncol; 1996 Jan; 1(1):49-61. PubMed ID: 9414388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.